Skip to search formSkip to main contentSkip to account menu

Xanafide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Xanafide, a DNA-intercalating agent and topoisomerase II inhibitor, has previously demonstrated comparable cytotoxicity to the… 
2007
2007
Secondary acute myeloid leukemia (sAML) evolves from a prior myelodysplastic syndrome (MDS) or myeloproliferative disorder (MPD… 
2005
2005
2065 Background: Amonafide malate (Xanafide, Xan) is currently under study in AIPC as an individualized therapy based on the rate… 
2005
2005
4988 Xanafide is currently in a phase 2 trial for the treatment of hormone refractory prostate cancer (HRPC). The taxanes have…